Nephros (NEPH) Current Assets (2010 - 2026)

Nephros' Current Assets history runs 17 years deep, the most recent figure standing at $11.5 million for Q1 2026.

• In Q1 2026, Current Assets rose 27.85% year-over-year to $11.5 million; the TTM figure through Mar 2026 stood at $11.5 million (up 27.85% YoY), while the FY2025 annual figure was $11.2 million, up 35.25% from the prior year.
• Current Assets was $11.5 million for Q1 2026 at Nephros, up from $11.2 million in the prior quarter.
• In the past five years, Current Assets ranged from a high of $11.7 million in Q1 2022 to a low of $7.4 million in Q3 2024.
• Historically, Current Assets has averaged $9.2 million across 5 years, with a median of $8.5 million in 2023.
• The sharpest annual moves came in 2022 and 2025: Current Assets sank 39.41% in 2022, then soared 45.54% in 2025.
• A 5-year view of Current Assets shows it stood at $8.3 million in 2022, then gained by 1.74% to $8.4 million in 2023, then decreased by 1.27% to $8.3 million in 2024, then soared by 35.25% to $11.2 million in 2025, then climbed by 2.43% to $11.5 million in 2026.
• The last three Current Assets figures came in at $11.5 million (Q1 2026), $11.2 million (Q4 2025), and $10.7 million (Q3 2025), per Business Quant data.